Regeneron Pharmaceuticals’ $256 million offer was chosen the winner of 23andMe’s bankruptcy auction. Drug research never became a big part of the genetic testing company’s business, but it is getting ...

GSK is expanding its prospects in hepatology, paying $1.2 billion to acquire a drug that goes after a clinically validated liver target but with a dosing advantage that could give it a competitive ...

After years of limited activity, the digital health sector is finally showing signs of life in the public markets. Only a few companies have filed to go public in recent years, including Waystar ...

President Trump’s executive order provides a framework for tying the prices of U.S. pharmaceutical products to the lower ...

UnitedHealth Group announced that Andrew Witty will step down as CEO due to “personal reasons.” He is being replaced by ...

Robert F. Kennedy Jr. testified before the House Committee on Appropriations and the Senate Health, Education, Labor and ...

The Department of Justice has filed a complaint against Aetna, Elevance Health, Humana, eHealth, GoHealth, and SelectQuote, alleging that the insurers paid illegal kickbacks to brokers to boost ...

The Business Group on Health is paying attention to Medicaid cuts, tariffs, threats to ERISA and more. There is no shortage ...

Automation startup Qventus launched a new AI assistant designed to alleviate healthcare staff’s administrative burden by completing mundane tasks for them. The assistant was built in ...

Pharmacies across the country are facing disruptions following a cyberattack on Change Healthcare — which is owned by Optum, a subsidiary of UnitedHealth Group. In a filing with the SEC ...

Through Maven's acquisition, Naytal’s over 50 providers will join Maven’s platform, more than doubling the company’s number of providers in the U.K. Maven will also be able to sign on ...